Despite notable progress over the last decade, tuberculosis is still a public health issue in most of the countries in the WHO European Region. Countries outside the European Union (EU) and the European Economic Area (EEA) still have a high rate of TB disease and multi drug resistance (MDR), while EU countries have a significant number of TB cases among vulnerable populations. Socio-economic determinants (level of training, occupation etc.) and risk factors (e.g. co-infection with HIV) also contribute to these high values.(1)